OMERS ADMINISTRATION Corp Makes New Investment in Agilent Technologies, Inc. $A

Key Points

• OMERS Administration Corp. bought 16,716 Agilent Technologies shares in the second quarter, valued at approximately $2.22 million. Several other institutional investors also increased or initiated positions.
• Agilent reported a strong fiscal third quarter, with revenue up 8.1% year over year to $1.88 billion and adjusted EPS of $1.62, beating analyst estimates. The company raised fiscal 2026 adjusted EPS guidance to $6.18–$6.21.
• Analysts maintain a consensus “Moderate Buy” rating with a $160.24 target price, but the stock’s valuation is relatively high at a P/E above 31 and shares are near their 52-week high.

OMERS ADMINISTRATION Corp bought a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 16,716 shares of the medical research company's stock, valued at approximately $2,220,000.

Other hedge funds have also recently modified their holdings of the company. Norges Bank acquired a new stake in Agilent Technologies during the 4th quarter worth $549,158,000. Bank of New York Mellon Corp boosted its stake in Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company's stock valued at $695,227,000 after acquiring an additional 2,440,360 shares in the last quarter. AQR Capital Management LLC boosted its stake in Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company's stock valued at $240,956,000 after acquiring an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company's stock worth $277,807,000 after purchasing an additional 1,340,161 shares during the last quarter. Finally, Findlay Park Partners LLP purchased a new position in shares of Agilent Technologies during the second quarter worth about $174,281,000.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on A. Wolfe Research reissued a "hold" rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. HSBC dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a research note on Wednesday, June 3rd. Weiss Ratings upgraded Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, June 2nd. Sanford C. Bernstein initiated coverage on Agilent Technologies in a report on Friday, June 26th. They issued an "outperform" rating and a $155.00 price objective for the company. Finally, Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a research report on Wednesday, May 27th. They set an "outperform" rating and a $153.00 target price on the stock. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $160.24.

Agilent Technologies Stock Up 0.3%

A opened at $155.16 on Thursday. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.51. The business has a 50 day moving average price of $139.16 and a two-hundred day moving average price of $126.65. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The company has a market cap of $43.82 billion, a PE ratio of 31.16, a P/E/G ratio of 2.73 and a beta of 1.25.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same quarter in the previous year, the company posted $1.37 earnings per share. The company's revenue for the quarter was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, research analysts anticipate that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

More Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the roughly $1.84 billion consensus estimate. Adjusted EPS of $1.62 exceeded estimates near $1.48-$1.49 and rose from $1.37 a year earlier. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability and cash generation strengthened. Operating profit increased 23.3% to $444 million, operating cash flow rose 43.4% to $519 million, and the company ended the quarter with $1.8 billion in cash. GAAP net income reached $362 million, or $1.28 per diluted share, versus $336 million, or $1.18, a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Agilent raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the approximately $6.06 consensus, and projected revenue of about $7.5 billion versus expectations near $7.4 billion. Management cited improving laboratory-tools demand. Fourth-quarter guidance was broadly in line with analyst estimates. Agilent Raises Annual Profit Forecast
• Neutral Sentiment: Institutional investor positioning was mixed: 594 investors increased holdings in the latest quarter, while 550 reduced positions. Recent analyst targets have a median of $155, suggesting limited near-term upside relative to the recent trading level.
• Negative Sentiment: Despite the earnings beat, Agilent trades at a relatively demanding valuation, with a P/E ratio above 31, and the stock is close to its 12-month high. This could make the shares more sensitive to any slowdown in laboratory-equipment demand or future guidance disappointments.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source